0001691421-20-000014.txt : 20201117 0001691421-20-000014.hdr.sgml : 20201117 20201117173052 ACCESSION NUMBER: 0001691421-20-000014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201104 FILED AS OF DATE: 20201117 DATE AS OF CHANGE: 20201117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Espinel Jorge CENTRAL INDEX KEY: 0001816039 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39367 FILM NUMBER: 201322163 MAIL ADDRESS: STREET 1: C/O LEMONADE, INC. STREET 2: 5 CROSBY STREET, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lemonade, Inc. CENTRAL INDEX KEY: 0001691421 STANDARD INDUSTRIAL CLASSIFICATION: FIRE, MARINE & CASUALTY INSURANCE [6331] IRS NUMBER: 320469673 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 CROSBY STREET STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: 9176089499 MAIL ADDRESS: STREET 1: 5 CROSBY STREET STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 4 1 wf-form4_160565223674208.xml FORM 4 X0306 4 2020-11-04 0 0001691421 Lemonade, Inc. LMND 0001816039 Espinel Jorge C/O LEMONADE, INC. 5 CROSBY STREET, 3RD FLOOR NEW YORK NY 10013 0 1 0 0 CBDO COMMON STOCK 2020-11-13 4 M 0 20000 5.26 A 20000 D COMMON STOCK 2020-11-13 4 S 0 3081 56.0427 D 16919 D COMMON STOCK 2020-11-13 4 S 0 9915 57.0934 D 7004 D COMMON STOCK 2020-11-13 4 S 0 3200 58.0658 D 3804 D COMMON STOCK 2020-11-13 4 S 0 1900 59.3368 D 1904 D COMMON STOCK 2020-11-13 4 S 0 1904 59.8987 D 0 D STOCK OPTION 59.7 2020-11-04 4 A 0 50000 0 A 2030-11-03 COMMON STOCK 50000.0 50000 D STOCK OPTION 5.26 2020-11-13 4 M 0 20000 0 D 2028-10-06 COMMON STOCK 20000.0 330000 D Represents sale pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.54 to $56.47. The reporting person undertakes to provide Lemonade, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.58 to $57.56 The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.61 to $58.595. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.625 to $59.575. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.785 to $60.08. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option will vest and become exercisable as to 25% on November 4, 2022, and in 12 equal quarterly installments thereafter beginning on February 4, 2023. The option is vested and exercisable as to 175,000 shares, and the remaining shares will vest and become exercisable in eight quarterly installments beginning on January 1, 2021. /s/ Timothy Bixby, Attorney-in-Fact for Jorge Espinel 2020-11-17